Anhui Tianhe Law Firm
Legal Opinion
Regarding Anhui Anke Bioengineering (Group) Co., Ltd.'s 2025 Annual General Meeting
To: Anhui Anke Bioengineering (Group) Co., Ltd.
Pursuant to the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Securities Law of the People's Republic of China" (hereinafter referred to as the "Securities Law"), the "Rules for Shareholders' Meetings of Listed Companies" (hereinafter referred to as the "Shareholders' Meeting Rules"), and the "Shenzhen Stock Exchange GEM Listed Company Regulation No. 2 - Normative Operation of GEM Listed Companies," Anhui Tianhe Law Firm (hereinafter referred to as "Tianhe" or "the Firm"), represented by lawyers Shishan Shan and Zhu Huayao, attended the 2025 Annual General Meeting of Anhui Anke Bioengineering (Group) Co., Ltd. (hereinafter referred to as "Anke Bio") or "the Company") to witness its legality and issue this legal opinion.
The Firm and the handling lawyers, in accordance with the "Securities Law," the "Administrative Measures for Securities Legal Business of Law Firms," and the "Practice Rules for Securities Legal Business of Law Firms (Trial)," and based on facts that have occurred or existed prior to the issuance date of this legal opinion, have strictly performed their statutory duties, adhered to the principles of diligence and good faith, conducted thorough investigations and verifications, and ensured that the facts identified in this legal opinion are true, accurate, and complete, and that the conclusions expressed are legal and accurate, without false records, misleading statements, or material omissions, and assume corresponding legal responsibilities.
In this legal opinion, the Firm's lawyers will only opine on whether the convening and holding procedures, the qualifications of attendees, the qualifications of the convener, and the voting procedures and results of this shareholders' meeting comply with the provisions of the "Company Law," laws, regulations, normative documents, and the "Articles of Association." The Firm will not comment on the truthfulness and accuracy of the content of the proposals discussed at the meeting or the facts or data stated therein.
The Firm's lawyers are unable to verify the qualifications of shareholders who voted online. Provided that the qualifications of shareholders who voted online meet the requirements of laws, administrative regulations, normative documents, and the "Articles of Association," the relevant attending shareholders are qualified. This legal opinion is for the sole purpose of witnessing the Company's shareholders' meeting and shall not be used for any other purpose.
In accordance with the requirements of relevant laws and regulations, and adhering to the generally accepted professional standards, ethical norms, and the spirit of diligence and good faith of the legal profession, the Firm's lawyers will provide legal opinions on the following matters concerning the convening and holding procedures of this shareholders' meeting, the qualifications of attendees, voting procedures, and other related legal issues:
I. Convening and Holding Procedures of this Shareholders' Meeting
(I) Anke Bio held the second meeting of the ninth board of directors on March 27, 2026, and passed the "Proposal on Convening the 2025 Annual Shareholders' Meeting." This shareholders' meeting was convened by the Company's board of directors.
(II) The notice of this shareholders' meeting was published in the information disclosure newspapers designated by the China Securities Regulatory Commission and on the website of the Shenzhen Stock Exchange 20 days prior to the meeting.
(III) The online voting period for this shareholders' meeting was April 24, 2026. Specifically, the online voting period through the Shenzhen Stock Exchange trading system was: April 24, 2026, 09:15 to 09:25, 09:30 to 11:30, 13:00 to 15:00; the voting period through the Shenzhen Stock Exchange internet voting system was: any time between April 24, 2026, 09:15 and April 24, 2026, 15:00.